Migraine Prevention in Patients Already on Propranolol for Anxiety

Primary Recommendation: Optimize Existing Propranolol

The American Academy of Family Physicians recommends propranolol dosing at 80-240 mg daily for migraine prophylaxis, with most patients achieving adequate control at 160 mg daily 1
Propranolol has been investigated in 46 controlled trials with consistent evidence for efficacy in preventing migraine attacks 2
An adequate trial requires 2-3 months at therapeutic dose before declaring treatment failure, as clinical benefits may not become apparent immediately 1
The patient is already receiving therapeutic benefit from propranolol for anxiety, and this same medication has the strongest evidence base for migraine prevention among beta-blockers 2, 3

Amitriptyline is the only antidepressant with fairly consistent efficacy in migraine prevention from controlled trials 2
The American Academy of Family Physicians suggests amitriptyline 30-150 mg at bedtime for patients with comorbid depression, sleep disturbances, or mixed migraine with tension-type headache features 4
Divalproex sodium or sodium valproate represents another first-line option with strong evidence for patients without contraindications, particularly women of childbearing potential 2, 1
Topiramate is a first-line option, particularly beneficial for obese patients or those with chronic migraine 4
Five controlled studies provide strong support for the efficacy of divalproex and valproate in migraine prevention 2

Propranolol is absolutely contraindicated in bradycardia, heart block (second or third degree), cardiogenic shock, and reactive airways disease 5
Use propranolol with caution in diabetes, as it may mask hypoglycemia symptoms 5
Limit acute rescue medications to less than twice per week to prevent medication overuse headache, which worsens migraine frequency and interferes with preventive treatment effectiveness 6, 4
Avoid interfering medications like ergotamine during preventive treatment 4

Naproxen sodium has modest but statistically significant effect on migraine frequency and can be considered 2
Verapamil showed significant differences in two of three placebo-controlled trials, though high dropout rates limit interpretation 2
Gabapentin has fair evidence of effectiveness but should not be prioritized over propranolol optimization or amitriptyline 1

Do not add another beta-blocker, as the patient is already on propranolol 2
Avoid beta-blockers with intrinsic sympathomimetic activity (ISA), as they are ineffective for migraine prevention 2
Do not discontinue propranolol abruptly, as this can cause rebound symptoms and acute myocardial ischemia 5
Do not declare treatment failure before allowing 2-3 months at therapeutic dose 1, 4